Scientists at the Technical University of Denmark have successfully used a combination of artificial intelligence (AI) and quantum computing to generate novel peptides, crucial steps in vaccine development. Working weekends with leftover funds from other projects, they ran their AI model alongside a printer-sized quantum computer built by British startup ORCA Computing, significantly improving the accuracy of peptide predictions. The team believes this hybrid approach could accelerate personalized immunotherapies and vaccines.

The research highlights the challenges in drug development, particularly in creating peptides that work across diverse populations where data is scarce. Dr Timothy Patrick Jenkins, who led the project, notes that 'most innovative science is too scary for foundations.' Despite such skepticism, his team's work shows promise, proving that even unconventional methods can deliver tangible results.

The findings come at a time when quantum computing remains in its infancy and faces intense scrutiny. Dr Jenkins was initially reluctant to explore the technology, but after learning that it could generate diverse images similar to what he needed for peptide predictions, he decided to give it a try. While not yet powerful enough to run full-scale models, the team's work demonstrates the potential of quantum computing in enhancing AI-driven drug discovery.

The project has garnered attention from industrial companies who see the technology as still too hazy and far away. However, this study could change that perception by showing a near-term commercial application for quantum. Dr Jenkins is now looking to expand his work with larger proteins and more cutting-edge models, particularly in neglected diseases that receive little research funding.